Narcolepsy sufferers in the Netherlands are getting a major breakthrough: a new drug called Orzeyful, approved in the US, targets the root cause of the condition by restoring a key brain chemical missing in narcolepsy patients. After decades of symptom management, this is the first treatment designed to fix the core problem. Early trial results are stunning—patients report feeling “normal again” and seeing the world clearly for the first time. While Europe’s approval is still pending, Dutch trial participants are already raving about the impact, despite minor side effects like increased urination. The sleep medicine community is buzzing—this could be a game-changer for millions.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
